The effect of ex vivo anticoagulants on whole blood platelet aggregation.
about
Platelet function in stored heparinised autologous blood is not superior to in patient platelet function during routine cardiopulmonary bypassTargeting von Willebrand factor and platelet glycoprotein Ib receptor.Enhanced pre-operative thrombolytic status is associated with the incidence of deep venous thrombosis in patients undergoing total knee arthroplastyWhich is the best anticoagulant for whole blood aggregometry platelet function testing? Comparison of six anticoagulants and diverse storage conditions.Comparison of Aggregometry with Flow Cytometry for the Assessment of Agonists´-Induced Platelet Reactivity in Patients on Dual Antiplatelet Therapy.Functional testing methods for the antiplatelet effects of aspirin.The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor mediated ex vivo platelet function in acute myocardial infarction.Dual antiplatelet therapy in patients with aspirin resistance following coronary artery bypass grafting: study protocol for a randomized controlled trial [NCT01159639].Comparison of Commercially Available Blood Collection Tubes Containing Sodium Citrate and Hirudin in Platelet Aggregation TestingIs TRAP-6 suitable as a positive control for platelet reactivity when assessing response to clopidogrel?Validation of a procedure to assess ASA-response in patients with decreased, initial TRAP induced aggregation.Platelet concentrates transfusion in cardiac surgery in relation to preoperative point-of-care assessment of platelet adhesion and aggregation.Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease.Assessment of platelet function by whole blood impedance aggregometry in coronary artery bypass grafting patients on acetylsalicylic acid treatment may prompt a switch to dual antiplatelet therapy.Rapid evaluation of platelet function using the Multiplate® Analyzer.Methodological considerations for the assessment of ADP induced platelet aggregation using the Multiplate® analyser.Effect of different anticoagulants on multiple electrode platelet aggregometry after clopidogrel and aspirin administration in patients undergoing coronary stent implantation: a comparison between citrate and hirudin.Evaluation of the INNOVANCE PFA P2Y test cartridge: sensitivity to P2Y(12) blockade and influence of anticoagulant.Evaluation of platelet aggregometry in dogs using the Multiplate platelet analyzer: impact of anticoagulant choice and assay duration.Bleeding risk-assessment in elective cardiac surgery - a reply.Preserved thrombin-inducible platelet activation in thienopyridine-treated patients.Desmopressin in vitro effects on platelet function, monitored with Multiplate, ROTEM and Sonoclot.Platelet function testing in hirudin and BAPA anticoagulated blood.Monitoring ASA and P2Y12-specific platelet inhibition--comparison of conventional (single) and multiple electrode aggregometry.Effects of prasugrel on platelet inhibition during systemic endotoxaemia: a randomized controlled trial.Evaluation of the role of the new INNOVANCE PFA P2Y test cartridge in detection of clopidogrel resistance.Platelet response to aspirin and clopidogrel in patients with peripheral atherosclerosis
P2860
Q28731224-CE74B8F0-2967-4F54-93A4-DC58B910F6F1Q33392975-730A1047-FEAE-48A9-99E9-C68BA8199945Q33891630-4B1FA353-5D6B-438D-84BF-19DC8423A066Q34224240-5FAA0B15-5BE1-48DB-9F47-0AF1EC92B825Q35658513-B9DC28B6-A7EC-47F8-96DA-4A0BAEB22878Q37841562-67DB8531-DB59-4D4D-BBCC-36FCD0A6E3ACQ38351931-7FEEC5FA-1B46-47FD-BC6B-3DDBC6CF7B45Q38465449-D002F548-3F95-45DA-A0A3-F4CACFAA99E6Q41252958-B0948A8E-57C9-4EC9-AEE1-31B0CDA148AFQ42972735-93BDCE2F-082C-4F5E-8337-2F3B51D55B77Q43076122-85A31351-182D-4DB1-9E5F-AEF63CC6A1ABQ43160871-3431FE4B-3735-4E45-A525-0EE99065CA30Q43545029-701BA583-4EF4-410B-A5D3-2DA4C9FE107BQ44196402-32542673-E3C4-45C2-B673-A214E2CF729EQ44398909-DCF8DEAD-D839-422C-BA7D-2DD5C83A6E31Q44664771-8CF57985-AA6A-409F-8712-70AF908625C2Q45797863-6EE3AE24-EA6D-46FA-8EC7-9D5D321D9EBAQ45872542-7A8AAA9B-7C13-467B-A393-8C5A5CC28EABQ46412456-F1C4EA7A-1AFE-443B-8620-1DA8B589EDA3Q47398835-A5A28E75-F0D7-44EF-8DDA-455B96BE38E3Q51049601-3F24556B-8F82-4F1C-B804-8749C5620D67Q53164239-2966D566-FF75-4CCB-89F0-11D1F294CBA3Q53281424-2B3135D4-9C22-45DE-B034-48A6261F54BDQ53420606-60F1C05A-F576-47A9-B5BD-77D9FB23C3F0Q54335457-E530FA06-8D2B-4D2D-BCA2-4AF43DB2D17CQ54546944-D48BC986-A33B-43E9-9974-8B1E1E854742Q57734957-B655C462-3976-48B0-9905-4144DB653D6E
P2860
The effect of ex vivo anticoagulants on whole blood platelet aggregation.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
The effect of ex vivo anticoagulants on whole blood platelet aggregation.
@en
The effect of ex vivo anticoagulants on whole blood platelet aggregation.
@nl
type
label
The effect of ex vivo anticoagulants on whole blood platelet aggregation.
@en
The effect of ex vivo anticoagulants on whole blood platelet aggregation.
@nl
prefLabel
The effect of ex vivo anticoagulants on whole blood platelet aggregation.
@en
The effect of ex vivo anticoagulants on whole blood platelet aggregation.
@nl
P2093
P2860
P1433
P1476
The effect of ex vivo anticoagulants on whole blood platelet aggregation.
@en
P2093
Gisela Scharbert
Lukasz Potura
Madeleine L Kalb
Sibylle A Kozek-Langenecker
P2860
P356
10.1080/09537100802364076
P577
2009-02-01T00:00:00Z